← FDA Drug Approvals (Drugs@FDA)
LINCOMYCIN HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SLATE RUN PHARMA · Approved 2022-12-21
Drug application
- FDA Application #
ANDA216662- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LINCOMYCIN HYDROCHLORIDE
- Generic name
- LINCOMYCIN
- Active ingredients
- LINCOMYCIN HYDROCHLORIDE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Discontinued
- Sponsor
- SLATE RUN PHARMA
- Manufacturer
- Slate Run Pharmaceuticals, LLC
- First approval
- 2022-12-21
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown